Speedcell – Vaccines  and Biologics for Global Health Crises.

Vaccines  and Biologics for Global Health Crises

To accelerate the development and production of biologics, enabling a swift response to health emergencies, aligned with the EU’s “100 Days Mission”

The SPEEDCELL project is a four-year EU-funded initiative led by HIPRA

Year project

EUR Funding

0 M

Time reduction goal in production

Days goal

Accelerate the development and production of biologics

The initiative focuses on optimizing development and manufacturing processes based on cell lines, widely used in the production of vaccines and biological products.

CHALLENGES

Reducing the
time-to-market

For new vaccines and therapeutic biologics in response to emerging health threats.

Manufacturing
infrastructure

Building a flexible, multi-technology manufacturing infrastructure capable of rapidly pivoting to new targets.

Production
scalability

Improving production scalability while maintaining product safety, efficacy, and quality.

Europe’s strategic
autonomy

Contributing to Europe’s strategic autonomy in the field of pandemic preparedness and biopharmaceutical production.

MISSION

SPEEDCELL’s mission is to boost Europe’s ability to respond to health emergencies by streamlining cell line development and manufacturing.

News

September 2025

Vaccines and Biologics for Global Health Crises

To accelerate the development and production of biologics, enabling a swift response to health emergencies, aligned with the EU’s “100 Days Mission”

Accelerate the development and production of biologics

SPEEDCELL, the new European project led by HIPRA, aims to reduce vaccine and biologics development to 100 days in emergency situations

Vaccines  and Biologics for Global Health Crises